Acquired resistance to first-line osimertinib is heterogeneous in EGFR-mutant advanced non-small cell lung cancer

J Jing Li J Jieyan Luo Z Zhanjun Dou M Mingxia Hou

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 29, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (4)

J

Jing Li

J

Jieyan Luo

Z

Zhanjun Dou

M

Mingxia Hou